Registry for managing pituitary diseases in China
China Pituitary Disease Registry Study
Shanghai Jiao Tong University School of Medicine · NCT04713293
This study is trying to create a better way to manage pituitary diseases in China by collecting and analyzing patient data to improve treatment and care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 14 Years to 75 Years |
| Sex | All |
| Sponsor | Shanghai Jiao Tong University School of Medicine (other) |
| Locations | 1 site (Shanghai, Shanghai) |
| Trial ID | NCT04713293 on ClinicalTrials.gov |
What this trial studies
The CAPASITY initiative aims to establish a comprehensive management model for pituitary diseases in China by utilizing an integrated online and offline platform. This observational study will create a multi-center prospective database to collect and analyze data on patients with pituitary adenomas and other related conditions. By leveraging advanced medical technology and big data analysis, the study seeks to evaluate treatment strategies, clinical outcomes, and the epidemiology of pituitary diseases across multiple centers. The goal is to improve the quality of care and long-term follow-up for patients suffering from these conditions.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 75 diagnosed with pituitary adenomas or other pituitary diseases.
Not a fit: Patients with significantly reduced life expectancy or those with active infectious diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could lead to improved diagnosis, treatment strategies, and overall management of pituitary diseases in China.
How similar studies have performed: While there have been various studies on pituitary diseases, the specific approach of integrating an online platform for comprehensive management is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years old and ≤ 75 years * Patients diagnosed with pituitary adenomas, and other pituitary diseases * Pituitary adenomas resected by transsphenoidal surgery were identified by histological diagnoses. * Gender: males and females * Provide written informed consent * Satisfactory compliance Exclusion Criteria: * Patients with significantly reduced life expectancy (less than 2 years) * With Drug abuse * With AIDS or syphilis or infectious diseases such as viral tuberculosis in active phase at enrollment
Where this trial is running
Shanghai, Shanghai
- National Metabolic Management center — Shanghai, Shanghai, China (RECRUITING)
Study contacts
- Principal investigator: Weiqing Wang, MD, PHD — National Metabolic Management center (Shanghai)
- Study coordinator: Weiqing Wang, MD, PHD
- Email: wqingw61@163.com
- Phone: 008621-64370045
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pituitary Disease, Pituitary Adenoma